2023.11.13

Genomtec received positive evaluation of Grant in Oncology Diagnostics from the Polish Agency for Enterprise Development (PARP) and the European Funds for a Modern Economy program

The Genomtec project, titled “Development of technology and an automatic system for mutation detection in clinical oncology based on ...
2023.09.28

Genomtec S.A. expands its Genomtec ID platform to oncology and has filed a patent application specific to oncology diagnostics

Genomtec has successfully completed the expansion of its Genomtec ID platform in the field of oncological diagnostics and has filed a patent ...
2023.07.07

The M&A process runs in parallel with research and development activities

– We are concentrating our efforts on multiple areas that are directly linked to the Genomtec ID platform. Our main focus lies in ...
2023.05.30

Genomtec at BIO International Convention

We are pleased to announce that Genomtec team (Miron Tokarski & Charudutt Shah) will attend BIO 2023 from Jun 5-8, 2023 in Boston. ...
2023.05.12

Interview with Miron Tokarski, CEO of Genomtec S.A. at Gazeta Giełdy i Inwestorów „Parkiet”

Key interview subjects: – Funds raised from the share issue will impact the realization of milestones and increase the value of ...
2023.04.27

Genomtec S.A. will raise PLN 13.1 million from share issue

Funds will increase the value of the Company’s technology in M&A transaction. More informtaion: ...